Načítá se...
Data on vildagliptin and vildagliptin plus metformin combination in type-2 diabetes mellitus management
It is of interest to evaluate the clinical effectiveness and safety of vildagliptin as monotherapy and combination therapy of vildagliptin and metformin for the management of type 2 diabetes mellitus (T2DM) patients in Indian settings. The study included patients with T2DM (aged >18 years) receiv...
Uloženo v:
| Vydáno v: | Bioinformation |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Biomedical Informatics
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8131578/ https://ncbi.nlm.nih.gov/pubmed/34092962 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6026/97320630017413 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|